Meridian Clinical Research, LLC.
Omaha, Nebraska, 68134, United States
NCT Number: NCT04628221
Prospective, Single Center, Open Label Clinical Study. The purpose of the study is to collect safety data associated with the use of the OsteoProbe System. Study Duration is expected to take approximately 3 months from first subject enrolled to the last follow-up visit.
Looking for future studies?
Notify Me22 year and older
All sexes
Interventional
Not applicable
Omaha, Nebraska, 68134, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The OsteoProbe® System ("OsteoProbe") is a bone microindentation measurement tool. The device is a measurement tool that is not intended to make a diagnosis or provide a treatment decision. There are no other available measurement tools for clinical assessment of bone's resistance to microindentation.
Time frame: Procedure
The number of participants who experienced device-related serious adverse events (SAEs) in subjects evaluated with the OsteoProbe System, per potential risks in the protocol.
Time frame: 1-day follow up visit
The incidence of device-related serious adverse events (SAEs) in subjects evaluated with the OsteoProbe System.
Time frame: 7-day follow up visit
The incidence of device-related serious adverse events (SAEs) in subjects evaluated with the OsteoProbe System.
Time frame: 30-day follow up visit
The number of participants who experienced device-related serious adverse events (SAEs) in subjects evaluated with the OsteoProbe System, per potential risks in the protocol.
Time frame: Post-procedure, 1-day, 7-day and 30-day follow up visits
The Numeric Rating Scale (NRS) is a continuous scale comprised of a line, with an eleven point numeric range (0 to 10) anchored by 2 verbal descriptors, one for each symptom extreme. The 0 mark corresponds to 'no pain', while the 10 mark corresponds to 'worse pain possible'. Therefore, higher scores indicate greater pain intensity. At all follow-up time points (post-procedure, Day 1, Day 7 , and Day 30), average was taken compared to baseline (Pre-Procedure).
Time frame: Procedure
BSMi Score is an output measure by the OsteoProbe device to measure bone tissue's resistance to microindentation which can be positively correlated with bone tissue quality.
Time frame: Procedure through day 30
The number of participants who experienced an adverse event.
Time frame: Procedure through day 30
The number of participants who experienced an device-related adverse event.
Time frame: Procedure through day 30
The number of participants who experienced a Serious adverse event.
Time frame: Procedure through day 30
The number of participants who experienced a Unanticipated adverse device effects.
Active Life Scientific, Inc.
Industry
A Single-Arm, Open Label Clinical Study to Collect Safety Data on the Osteoprobe System When Used as a Measurement Tool
Acronym: OP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.